학술논문
Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib
Document Type
Article
Author
Source
In Leukemia Research April 2019 79:38-44
Subject
Language
ISSN
0145-2126